SMAD3 and lung cancer: Furthermore, phosphorylation levels of SMAD3 in CD3, CD8, Foxp3, and CD68 cells in non-small cell lung cancer negatively impact the overall and partial disease-free survival in lung cancer patients, independent of histological subtype.